BRCA2 and leiomyosarcoma: One patient (1.4%) with leiomyosarcoma that was HRD+ and had a germline BRCA2 mutation experienced confirmed CR, seven patients (10.1%) achieved PR, and 32 patients (46.4%) had SD.